Kidney injury is a common clinical feature among liver transplantation (LT) candidates that heavily affects prognosis and complicates the surgical decision-making process. Up to 20% of patients undergoing LT demonstrate some degree of renal impairment, and 2% will benefit from a combined liver-kidney transplantation (LKT). We present a case-control study of all patients who underwent LKT and combined liver-dual kidney transplantation (LDKT) from November 2013 to March 2016. For the selection of LDKT candidates, a histological-based algorithm was applied: when evaluating extended criteria donors (ECDs), with any Remuzzi score between 4 and 7, we would consider performing a LDKT instead of a simple LKT. Study groups were similar for recipient variables. In the LDKT group, donor age, donor risk index, and donor body mass index were found to be significantly higher. Biopsies obtained from all pairs of kidney grafts in the LDKT group demonstrated the following Remuzzi scores: 414, 414, 711, 415. Despite longer operative times for the LDKT procedure, no differences were observed regarding the main investigated outcome parameters. Overall survival was 100% (LDKT) and 91% (LKT, P > 0.99). This is a preliminary experience which might indicate that LDKT is a safe, feasible, and resource-effective technique. The evaluation of a larger cohort, as well as the experience from other centers, would be needed to clearly identify its role in the ECD era.
Acute or chronic renal dysfunctions are clinical features often found among end-stage liver disease patients. In the subpopulation of transplant candidates, the presence of renal injury may heavily affect prognosis before and after surgical treatment and increase the complexity of any medical and surgical decision-making process. It has been reported that a percentage of up to 20% of patients undergoing liver transplantation (LT) demonstrate some degree of renal impairment and, among these, 2% will benefit from a combined liver-kidney transplant (LKT).
(1) Hereditary conditions affecting both organ systems (such as autosomal dominant polycystic kidney disease [ADPKD]), metabolic diseases, and coexisting liver and kidney impairment (hepatorenal syndrome [HRS] ) are the most common indication for LKT. The results of the combined procedure, in terms of overall patient and graft survival, (2) have confirmed its role as the surgical therapy of choice in all patients with irreversible kidney injury who are not expected to improve their renal function after an isolated orthotopic liver transplantation (OLT). (3, 4) In our experience, the high Model for EndStage Liver Disease (MELD) score priority given to patients listed for LKT does not necessarily translate into an advantage in terms of time on the waiting list. With extended criteria donors (ECDs) (5) accounting for more than half of the donor pool in Europe now, it is increasingly hard to procure both a suitable liver and kidney from the same donation; therefore, patients listed for a combined procedure are often subject to longer times on the waiting list compared with recipients awaiting an isolated OLT procedure. Dual kidney transplantation (DKT) has attracted interest in the ECD era because it allows the usage of suboptimal organs that were previously discarded while ensuring similar, if not better, results compared with single kidney transplantation. (6) DKT has been successfully listed among the strategies to optimize the scarce organ resource (and preliminary experiences with DKTs performed with organs from donations after cardiac arrest have shown a promising acceptability, albeit with inferior graft and patient survival (7, 8) ). With these premises in mind, we decided to consider the possibility of performing a combined liver-dual kidney transplantation (LDKT) procedure, balancing the increased surgical complexity against the ability of procuring all the organs from a single ECD. Because our experience with liver grafts procured from suboptimal donors, in accordance to literature, has shown that their routine use is safe with acceptable results, (9, 10) the main objective of our experience was to investigate whether the combination of a DKT was possible and safe. To improve the quality of our analysis, we decided to compare the performance of the procedure with LKT with the aim of assessing whether it would allow comparable outcomes and also reduce the time on the waiting list for combined procedure candidates.
Patients and Methods

STUDY DESIGN
We present a case-control study including all patients who underwent LKT and LDKT in a period ranging from November 2013 to March 2016 at our institution. The investigated population, composed of a total of 15 patients, was allocated to the control or study groups depending on which procedure was performed. The study group was composed of 4 (26.7%) patients who underwent LDKT. All the recipients were selected among the candidates listed for a LKT procedure during the study period at our center. The results were retrospectively analyzed using a prospectively updated database: donor and recipient demographic characteristics, as well as the most relevant outcome, and biochemical and technical variables were compared among the 2 groups. The perioperative period was defined as the 90 days after the procedure.
LDKT CANDIDATE SELECTION
Preliminary identification of potential LDKT candidates was based on the assessment of all factors that could further increase surgical complexity such as previous abdominal or pelvic surgery, previous kidney transplant, or severe vascular disease of the iliac axis (atherosclerosis or thrombosis). The presence of any of these factors was not considered an absolute contraindication to the procedure but rather included into a broader, multidisciplinary evaluation of each patient's comorbidities. We decided to introduce delta-age (age difference between recipient and donor) as an additional guiding parameter: we set the ideal inferior age limit for LDKT candidates to 55 years with the intention of keeping the lowest possible delta-age. This decision had the aim of preferentially allocating the oldest grafts to the oldest recipients. After this preliminary evaluation, we designed the allocation criteria for LDKT candidates by extending the selection algorithm for DKT, which is based on the pathology report of kidney biopsies. When evaluating donations from an ECD, we would assess pretransplant Remuzzi scores and, as in DKT, with any score between 4 and 7, we would consider performing a LDKT instead of a simple LKT. We allowed the sum of each kidney's individual score (maximum total Remuzzi score) to be no higher than 12: in the event of both kidney grafts being unsuitable for any transplant procedure, with a suitable liver graft (macrosteatosis lower than 30% of the parenchyma, absence of bridging lobular necrosis or severe portal inflammation, fibrosis stage <2 according to the Ishak score), (11, 12) a different candidate would be chosen to undergo OLT. In this experience, ECD was defined as a donor older than 60 years with clinical risk factors or older than 70 years regardless of clinical history. The assessed risk factors were the following: creatinine clearance 60 mL/minute, evidence of proteinuria on a single urine sample, arterial hypertension treated with at least 2 drugs, diabetes mellitus type 1 or 2, and a positive history for cardiovascular complications. (13) Kidney and liver biopsies were always performed during the "warm" phase of organ procurement, before cross-clamping and cold perfusion; this allowed the possibility of obtaining the pathology report, a lengthy process (up to 3 hours), in time for making allocation decisions before the beginning of any procedure on the candidate recipient. Final candidate selection went through the testing of the likelihood of donor-specific antibody-mediated response, cross-matching donor lymphocytes and potential recipients' serums. Figure 1 summarizes the individual steps, from the multidisciplinary evaluation to the final allocation decisions.
SURGICAL TECHNIQUE
In all cases, we performed liver and kidney transplants sequentially using a "liver first" approach. OLT was performed using the piggyback technique with end-to-side cavocavostomy (using the recipient's suprahepatic cuff), end-to-end portal and arterial anastomoses (between the graft's hepatic artery proper and the recipient's common hepatic artery at the branching of the gastroduodenal artery). Biliary reconstruction was always obtained with duct-toduct biliary anastomosis, without the placement of Kehr's T-tubes. As a general rule, we tend to implant renal grafts respecting the original anatomic side (ie, a left kidney on the recipient's left iliac axis): in LDTK, however, the kidneys were extraperitoneally implanted bilaterally in the iliac fossae, using 2 separate J-shaped incisions. In one case, we decided to implant both grafts ipsilaterally on the same iliac axis, therefore preserving the contralateral iliac vessels. In both LDKT and LKT, either 1 or 2 ureterovesical anastomoses were accomplished using the LichGregoir antireflux technique.
STATISTICAL ANALYSIS
All results are summarized in the text as means, unless differently stated each time. Measures of variability are reported in Tables 1 and 2 using mean and standard deviation (SD). When reporting medians, measures of variability are indicated as interquartile range, minimum value, and maximum value. Difference between population means were obtained using the 2-sample t test; difference between population proportions were obtained with the chi-square test and Fisher's exact test. Overall survival was calculated from the date of procedure to the date of last follow-up evaluation or patient death. Graft survival was calculated from the date of LDKT or LKT to the date of last follow-up evaluation, graft loss, or patient death. Statistical significance was defined by a P value of less than or equal to 0.05. Statistical analysis was performed with the STATA software package, version 14 (StataCorp LP, College Station, TX).
Results
DONOR AND RECIPIENT CHARACTERISTICS
Mean recipient age for the study and control group was 57 and 52, respectively (P 5 0.24); 50% (n 5 2) of patients and 36.4% (n 5 4) of controls were female (P 5 0.63). In the LDKT group, mean donor age was significantly higher compared with LKT (75 years versus 38 years; P < 0.001) and so was the mean donor risk index (DRI) (14) value (1.84 and 1.18; P < 0.001). Mean donor body mass index (BMI) was found to be significantly higher in the LDKT group (P < 0.01). Other characteristics of both recipients (BMI, MELD at transplantation, indication for LT and kidney transplantation [KT], human leukocyte antigen [HLA] matches, induction immunosuppression) and donors (causes of death) are listed in Table 1 .
HISTOLOGICAL ASSESSMENT
As is our customary practice when evaluating liver grafts from ECD, in the study group liver biopsy was always performed with unremarkable results (maximum percentage of macrosteatosis (14) <10%, no evidence of fibrosis), and 18.2% (n 5 2) of liver grafts in the control group underwent pretransplant biopsy. As the algorithm dictates, in the LDKT group biopsies were obtained from all pairs of kidney grafts and Remuzzi scores were the following: 414, 414, 711, 415 (in the control group, we only performed 2 biopsies with scores equal to 1 and 1).
WAITING TIME AND PROCEDURE
Median time on the waiting list was 89 days for the LDKT group and 118 days for controls (P 5 0.06). The LDKT procedure took, on average, more time than the standard LKT as was indicated by longer operative times (14.8 for LDKT and 11.1 hours for the control group; P < 0.003). Mean total length of intensive care unit (ICU) and hospital stay, in days, as well as mean duration of cold ischemia time (CIT) for kidney and liver grafts were not found to be significantly different among groups, and the values are listed in Table 2 . 
PERIOPERATIVE COMPLICATIONS
We reported 1 death within 90 days after the procedure, which occurred in the control group (P 5 0.53). Two (50%) patients in the study group suffered from perioperative complications against 6 (55%) in the control group (P 5 0.87). We had radiological evidence of stenosis of the biliary anastomosis treated with endoprosthesis placement via ERCP in 2 LDKT recipients plus 1 patient with carbapenem-resistant Klebsiella pneumoniae (CRKP)-sustained sepsis treated with prolonged antibiotic therapy and 1 episode of transient ischemic attack. Complications that occurred within 90 days from the procedure in LKT recipients are also listed in Table 2 . We did not observe any event of primary liver graft nonfunction in any of the patients, and delayed kidney graft function was observed in 1 (25%) LDKT and 4 (36%) LKT recipients (P 5 0.68).
FOLLOW-UP AND SURVIVAL DATA
Median follow-up was 236 and 472 days for LDKT and LKT patients, respectively (P 5 0.11). At the end of the observation period liver graft survival was 100% and 91% (LDKT and LKT; P > 0.99), whereas kidney graft survival remained 100% in the study group and 82% in the LKT group (P > 0.99, 1 patient underwent transplantectomy due to recurrent episodes of infection that eventually led to graft loss 3 months after the procedure). Overall survival in the LDKT group was 100% and 91% in the control group (P > 0.99).
Discussion
We started to investigate the possibility of combining LT with a DKT when searching for a strategy to perform combined transplants even with suboptimal, marginal donors. The characteristics of our donor pool mimic exactly the current European situation, with the majority of donor calls now referring to ECDs. At the moment of writing, 14% of candidates currently active on our center's waiting list are listed for a combined procedure. The experience with the first cases of LDKT supported our impression of the feasibility and safety of the technique that was further corroborated by the case-control study that is discussed in the article. As the groups appeared matched in regard to the investigated recipients' variables, the first important differences emerged when the analysis of the donors' characteristics gave confirmation of the intended recruitment strategy: donors allocated to LDKT fit more consistently in the ECD category compared with *For LDKT, the mean of both kidneys' CITs was used to perform the computation. † The numbers shown to the right of each listed complication represent the number of times the complication occurred in each group of patients.
the LKT group, which was more heterogeneous regarding donors' clinical characteristics. An increase in surgical complexity was unsurprisingly encountered during the operations, as shown by statistically longer mean operative times, but the lengthening of the procedure did not prove to be harmful to kidney grafts in terms of longer CIT nor did the increased complexity translate into a higher likelihood of perioperative complication or an increased ICU or hospital stay. An important aspect was the occurrence of delayed kidney function, defined as the need of at least 2 hemodialysis treatments in the first week after the procedure, which seemed to be unrelated to whether 1 or 2 kidneys were being transplanted. We also wanted to investigate if LDKT would allow a reduction in time on the waiting list for combined procedure candidates: we did observe a trend toward shorter time on the waiting list for LDKT recipients with a P value equal to 0.06 (1 patient from the LKT group was censored for being transplanted as a national urgency after only 2 days of being listed). To maximize the efficiency of the technique, we think that any algorithm for the selection of potential LDKT recipients should take into account the delta-age (which is based on the concept of age mapping (15) ): ideal candidates for the LDKT procedure are middle to old age (we propose a lower age limit of 55 years) who are best suited to receive organs from older ECDs. This was indeed one of the limits of our study because keeping a consistently low delta-age proved to be difficult. When evaluating younger recipients, the application of the LDKT strategy is more controversial because the selection of non-ECD donors for these patients who are suitable for a simple combined procedure might still be the preferred strategy. We believe that, during organ procurement, obtaining kidney graft biopsies before cross-clamping allows for a better optimization of time before allocation, and it should be considered the preferred approach to histological evaluation for the LDKT strategy. One interesting aspect that emerged during follow-up of the patient who received the score 7 kidney is the report of a renal scintigraphy performed 1 year after the LDKT, which described a contribution of 60% to total glomerular filtration rate by the former score 7 kidney (the other kidney being a Remuzzi score 1). The interpretation of this result is enigmatic and may further embitter the discussion about the appropriateness of allocation decisions based on pretransplant biopsy scores. One more consideration is on surgical technique: in all but 1 LDKT, we chose to perform the DKT bilaterally, using separate incisions. For younger patients (those closer to the age limit of 55 years), for whom a higher risk of developing chronic kidney injury in the longterm follow-up period can be predicted, we think that the strategy of transplanting both kidneys on the same iliac axis (a technique we employed in 1 of the patients), possibly sparing the contralateral vessels in case of the need of a new transplant procedure, should always be considered. Although limited by the small number of involved patients and by the short follow-up period, our preliminary experience is encouraging, and it might indicate that LDKT is a safe, feasible, and resource-effective technique. The evaluation of a larger cohort, as well as the experience from other centers, would be needed to clearly identify its role in the ECD era.
